Showing 849–864 of 1142 results
The P1NP – Intact N-Terminal Propeptide test measures bone formation activity. Ideal for osteoporosis monitoring. Results in 10 days. Book your test today.
Sample Type : Serum
Methodology : Electrochemiluminescence
TAT : 10 Days
Sample Type : 24 Hour Urine
Methodology : Spectrophotometry
TAT : 10 Days
Sample Type : Random Urine
Methodology : Spectrophotometry
TAT : 10 Days
Get the Panorama Basic NIPT in Dubai from 10 weeks. Screen for Down syndrome, trisomies & microdeletions with 99% accuracy. Non-invasive blood test. Results in 7-10 days. Book now!
Sample Type : Maternal blood
Methodology : PCR-single nucleotide polymorphism (SNP)-based technology
TAT : 7-10 Days
Panorama Extended Prenatal Screening is a cutting-edge, non-invasive prenatal test (NIPT) designed to provide expectant parents with critical insights into their baby’s health.
Sample Type : Maternal blood
Methodology : PCR-single nucleotide polymorphism (SNP)-based technology
TAT : 10 Days
Sample Type : Maternal blood
Methodology : PCR-single nucleotide polymorphism (SNP)-based technology
TAT : 10 Days
Sample Type : Serum
Methodology : Chemiluminescence
TAT : 2 Days
PCOS PACKAGE
PCR for HLA-B27 (EDTA) is a molecular diagnostic test used to detect the HLA-B27 gene, which is strongly associated with autoimmune disorders like ankylosing spondylitis and other spondyloarthropathies. Utilizing Polymerase Chain Reaction (PCR) technology, this test offers high sensitivity and specificity, ensuring accurate and reliable results.
The PD-L1 (22C3) Dako CPS (IHC) test is an immunohistochemistry (IHC) assay designed to assess PD-L1 expression in tumor and immune cells using the Combined Positive Score (CPS). It is FDA-approved as a companion diagnostic for multiple cancer therapies, ensuring precise patient selection for immune checkpoint inhibitors. The test utilizes the 22C3 monoclonal antibody, providing high sensitivity and specificity in detecting PD-L1 expression. Its standardized scoring system (CPS) enhances reproducibility and clinical decision-making, making it a trusted tool for oncologists. The Dako platform ensures consistent, high-quality staining, supporting accurate and reliable results for personalized cancer treatment.
PERIMENOPAUSE PACKAGE
Sample Type : Random Urine
Methodology : Immunochromatography
TAT : 4-5 Day